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Abstract: Background: Social and health inequities predispose vulnerable populations to adverse
morbidity and mortality outcomes of epidemics and pandemics. While racial disparities in cumulative
incidence (CmI) and mortality from the influenza pandemics of 1918 and 2009 implicated Blacks
with survival disadvantage relative to Whites in the United States, COVID-19 currently indicates
comparable disparities. We aimed to: (a) assess COVID-19 CmI by race, (b) determine the Black–White
case fatality (CF) and risk differentials, and (c) apply explanatory model for mortality risk differentials.
Methods: COVID-19 data on confirmed cases and deaths by selective states health departments
were assessed using a cross-sectional ecologic design. Chi-square was used for CF independence,
while binomial regression model for the Black–White risk differentials. Results: The COVID-19
mortality CmI indicated Blacks/AA with 34% of the total mortality in the United States, albeit their
13% population size. The COVID-19 CF was higher among Blacks/AA relative to Whites; Maryland,
(2.7% vs. 2.5%), Wisconsin (7.4% vs. 4.8%), Illinois (4.8% vs. 4.2%), Chicago (5.9% vs. 3.2%), Detroit
(Michigan), 7.2% and St. John the Baptist Parish (Louisiana), 7.9%. Blacks/AA compared to Whites in
Michigan were 15% more likely to die, CmI risk ratio (CmIRR) = 1.15, 95% CI, 1.01–1.32. Blacks/AA
relative to Whites in Illinois were 13% more likely to die, CmIRR = 1.13, 95% CI, 0.93–1.39, while
Blacks/AA compared to Whites in Wisconsin were 51% more likely to die, CmIRR = 1.51, 95%
CI, 1.10–2.10. In Chicago, Blacks/AA were more than twice as likely to die, CmIRR = 2.24, 95%
CI, 1.36–3.88. Conclusion: Substantial racial/ethnic disparities are observed in COVID-19 CF and
mortality with Blacks/AA disproportionately affected across the United States.
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1. Introduction
The understanding of the social gradient, implying the social determinants of health and
health-related events is essential in transforming health equity in epidemics and pandemics. Health
distributions and determinants reflect social inequity, which is the unfair and unjust distribution of
social, economic and environment conditions associated with health [1] resulting in health disparities
and inequitable outcomes of morbidity and mortality [2,3]. Whereas smoking, physical activities,
unhealthy nutrients and excessive alcohol consumption have been linked to health outcomes due to
decreased immune responsiveness and abnormal cellular differentiation and maturation [3,4], the
understanding of these determinants in infectious diseases, such as COVID-19, is relevant in epidemic
curve flattening and case fatality mitigation. Epidemiologic data clearly implicate the sub-populations
characterized by low education, low socio-economic status, disadvantaged or deprived neighborhoods
with excess morbidity and mortality in any epidemic and pandemic [5,6], relative to socio-economically
advantaged [7,8]. Translational epidemiology that involves research at biologic, clinical correlates
and population-based levels provides the perspective and challenges in addressing and transforming
health equity during pandemics such as COVID-19.
Translational epidemiology requires causal chain model in addressing epidemics and pandemics,
which should be based on the social determinants of health (SDH), such as the conditions in
environments in which people live, learn, work, worship, age and play. Specifically, these conditions
reflect the availability of resources in addressing quality education, economic stability, health and
healthcare needs, safe neighborhood and built environment, as well as social and community context [9].
These attributes of SDH reflect the social gradient in health, implying impaired health outcomes
for the socially disadvantaged such as low socio-economic status (SES) relative to the socially
advantaged (wealth, income, high education). Available data on pandemic history, such as H7N9
implicate poverty, inequity, and SDH in infectious disease transmission and the associated burden of
morbidity and mortality [10]. The 2009 H1N1 influenza pandemic observed differential mortalities by
socio-demographic [10] as well as substantial geographic variation [11] and population density [12].
In addition, the H1N1 pandemic observed an increased rate of hospitalization among the poor and
those residing in poor neighborhoods as well as racial/ethnic minorities in the US [13]. Observed in
the 1918–1920 flu pandemic mortality was low SES as per-head income associated with healthcare
access, care utilization, nutritional status and comorbidities [14]. A study on the flu pandemic
in 1918 in Chicago observed significant disparities in transmission and mortality associated with
socio-demographics namely population density, illiteracy, unemployment, and age. Specifically, in
relation to illiteracy, the multivariable model after controlling for population density, homeownership,
employment and age, showed a 32.2% increased mortality risk for every 10% increase in illiteracy [15].
Blacks/African Americans (AA) as racial minorities are disproportionately affected by almost all
pathologies in the US except tuberculosis (TB), cystic fibrosis, suicide, alcoholism and unintentional
injuries as in motor vehicular accidents [16]. This population experienced excess adverse outcomes
and morbidities, which had been attributed to social inequity and health inequity as exposure function
of the SDH [17], psychosocial stressors and unfair and unjust incarcerations. A recent review of
race and 1918 influenza pandemic in the USA observed lower transmission (13% vs. 25%) among
Blacks but higher case fatality (1–2% vs. 2–3%) relative to Whites [18]. The current COVID-19 global
pandemic, caused by SARS-COV2, a ribonucleic acid (RNA) single-stranded enveloped pathogenic
microbe remains very virulent, with the potential to be transmitted by asymptomatic individuals or
carriers. While population density increases the risk of COVID-19 as observed in New York City,
Detroit and Los Angeles, race as a socio-demographic factor may play a role in transmission as well as
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mortality and higher case fatality among Blacks/AA compared to their White counterparts. Moreover,
relevant to increased or differential exposure to SARS-COV2 is low-income households, as reflected in
Blacks/AA residing in apartment complexes and crowded neighborhoods in the US. The higher case
fatality among Blacks/AA reflects the poorer health outcomes as observed in Cardiovascular Diseases
(CVDs), hypertension, malignant neoplasm, diabetes, asthma, bronchopulmonary diseases, such as
Chronic Obstructive Pulmonary Disease (COPD), and immunologic disorders [19,20]. These adverse
health outcomes of Blacks/AA relative to their White counterparts reflects a lack of insurance, limited
access to primary care provider and racial discrimination in the process of care navigation [21,22].
Regarding viral spread, contact with the exposed individual, either symptomatic or asymptomatic
as in SARS-COV2 increases the transmission, which explains the rationale for increased transmission
and mortality among Blacks/AA who reside in dense population areas with crowded housing and
suffer adverse environmental neighborhood factors, such as limited green spaces, recreational facilities,
safe playgrounds and transportation systems. Blacks/AA relative to their White counterparts are more
likely to use public transportation systems such as transit buses, which carries a higher probability
of contact with infected COVID-19 cases, increasing the risk of infectivity among Blacks/AA [23].
Since a respiratory virus such as SARS-COV2 compromises the airways resulting in acute respiratory
distress syndrome, previous exposure to environmental pollutants and toxins precipitates poor
prognosis. Such would be the case in a population associated with exposure to environmental toxins
and pollutants, particular Blacks/AA [24].
With evidence-based data assessment from pandemics and epidemics, reflecting higher case
fatality among the socially disadvantaged, such as the poor, underserved and Blacks/AA (racial
minority), this study intends to examine the current experience of COVID-19 in recommending urgent
equitable preparedness in addressing mortality and case fatality in the United States. With structural or
organized racism as the main predisposition of Blacks/AA to excess pandemic mortality, the application
of the public health disproportionate universalism that mandates equitable allocation of resources
necessary for optimal health and enhanced survival, should be urgently implemented. The assessment
of these variables such as income, SES, health insurance, safe neighborhood environment, access
and utilization of quality healthcare, and lifestyles such as smoking, vaping, alcohol, drugs, physical
inactivity, which are implicitly driven by structural racism, allow for an effective intervention mapping
in addressing what is “avoidable” and “unacceptable”, social inequity as an exposure function of
health inequities and disparities in morbidity and mortality.
The pathogenicity and virulence of a microbe depends on its ability to bridge the innate and
adaptive immune response. The subpopulations with exposure to circumstance, such as food insecurity,
psychosocial stressors and chronic morbidity have an increased propensity for viral transmission
and infectivity complication, resulting in increased mortality and case fatality. Within the Black/AA
communities, these exposures, in addition to the lack of health insurance, render the immune system
incompetent through several mechanisms. One such mechanism refers to the propagation of the
conserved transcriptional response to adversity (CTRA) gene, resulting in an adverse consequence on
interferon system elaboration during viral infection and decreased antibodies such as immunoglobulin
G (IgG) synthesis. In addition, patients’ response to therapeutic agents, such as monoclonal antibodies,
anti-inflammatory and antiviral drugs, depend on transcriptomes, which serve as receptors to drugs or
medications, or a lack thereof, which implies a decreased response to therapeutic agents. This current
study aimed to assess the disproportionate burden of COVID-19 on Blacks/AA relative to Whites, explain
the root causes, implying the social gradient and propose scientific and data-driven recommendations
in narrowing the gap in case fatality between Whites and Blacks/AA. Specifically, we sought to: (a)
examine the frequency of confirmed cases in the United States and, by region and states, namely
Illinois, Michigan, Louisiana, Wisconsin, Maryland, New York and California, (b) assess the cumulative
incidence (CmI) of COVID-19 mortality by race, and (c) determine the case fatality differentials between
Blacks/AA and Whites.
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2. Materials and Methods
This study was proposed to examine the exposure function of race as a socio-demographic
factor associated with COVID-19 transmission, mortality and case fatality, with the intent to make
recommendations for equitable resources during infectious disease epidemic and pandemic. With this
initiative epidemic curve flattening and case fatality mitigation remains the norm in a pandemic in
the USA.
2.1. Study Design
Data simulation and cross-sectional ecologic design was used to assess aggregate data on COVID-19
in selected states (WI, MI, LU, IL, MD, NC, NJ, NY, CA) by race. This design allows for an assessment
on the correlation between the frequency of COVID-19 confirmed cases, mortality, case fatality and
race. The data simulation was performed using data from the 2009 H1N1 with signal amplification and
specific risk stratification by race. The data on risk modeling were available on the following states
namely WI, MI, LU, IL, MD.
2.2. Study Population and Data Source
The population of interest were geographic clusters by geographic locale such as states and
race. These states were selected based on previous studies on H1N1 influenza pandemic and the
observed health disparities, with Blacks/AA representing the subpopulation with highest morbidity
and mortality. The data sources utilized were the state department of health that provide COVID-19
cases and mortality by gender, county or location, age and race. However, these data, although
reliable, were not very inclusive, since race data were not available for some COVID-19 confirmed
cases and deaths.
2.3. Variables Ascertainment
Race as the exposure function of laboratory confirmed cases of SARS-COV2 with ribonucleic acid
(RNA) sequencing high-throughput process and mortality was self-reported from all tested individuals,
positive or negative. The confirmed cases were based on either state or private laboratory tests on the
viral RNA antigen. Other variables available for public access included age, gender, hospitalization,
recovered cases and location of cases such as county, city, state, etc.
2.4. Statistical Analysis
Data simulation involved the use of an immediate risk ratio to assess the 2009 N1H1 2009 influenza
pandemic data. This was performed by cumulative incidence risk. The ecologic or aggregate data on
COVID-19 from the states’ public access data was used to determine racial variances or differences in
confirmed cases and mortality. The case fatality was performed using the formula:
COVID-19 deaths/COVID-19 frequency or confirmed cases × 100.

(1)

To determine the racial trends in the case fatality, we utilized the percent change by race:
recent case fatality (RCF)-previous or baseline case fatality (BCF)/BCF × 100.

(2)

The burden of the disease COVID-19 as a ratio of the shared contribution of subpopulations to the
overall mortality was estimated using the formula:
proportion or percentage of deaths in subpopulation within the domain/the US
Census 2020 estimated percentage of the subpopulation.

(3)
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For example, if the proportion or percentage of death in population A = 46% based on the total
number of deaths in the overall population, and the population size of that population (A) = 14%, the
COVID-19 burden for that population = 46/14 = 3.3, implying a disproportionate burden of death in
population A.
The binomial regression model (BRM) was used to determine the risk of dying from COVID-19 by
specific populations in the race category. This model is adequate in predicting the risk of dying from
COVID-19 and by race stratification. The BRM is based on the probability of dying in the populations
of interest, namely Whites and Blacks/AA, and with Whites as the selected population in the referenced
group for the relative risk assessment, as the risk ratio point estimate or magnitude of effect. In this
model, we predicted the risk of dying, given the race of the confirmed COVID-19 case. The response or
dependent variable ‘y’ (COVID-19 deaths), with each value in the independent variable (race/ethnicity)
representing the number of success (k-deaths) observed in ‘m’ trials. Assuming the probability of
success (death) = π, and the probability of failure (alive) = 1 − π. We used the link function to relate
the risk of dying to a linear combination of the regression variable, including the constant or intercept
on the y axis:
ln (pr (success (death) = 1/pr (success (death) = 0) = β0 (constant/intercept) + β1(race).

(4)

For example, the risk of dying from COVID-19 among Blacks/AA was compared to the risk of
dying among Whites for the risk ratio estimation using 2 × 2 tabulation (A/AB)/(D/CD), A = Confirmed
cases and COVID-19 mortality among blacks, B = Confirmed cases with recovery/survival among
blacks, C = conformed cases and COVID mortality among whites, while D is confirmed cases with
recovery/survival among whites. A/AB is the risk in the exposed, Blacks/AA, divided by the risk in the
unexposed, Whites, D/CD. In terms of the interpretation, if the two populations are comparable with
respect to the mortality risk, the risk ratio (RR) = 1.00, and if the risk is higher among Blacks/AA, the
RR is >1.0, but if the risk of COVID-19 is lower among Blacks/AA, the RR is <1.025 .
The type I error tolerance was set at 0.05 (95% CI) and all tests were two tailed. The entire analysis
was performed using STATA, Version 15.0 (Stata Corp, College Station, TX, USA).
3. Results
These data reflect confirmed cases of COVID-19 and mortality by race from selected states where
these data are currently available. Although not on the table, the case fatality of SARS-COV2, the
causative pathogen in COVID-19 in the United States as per 04/14/20 was 4.11%, with New York,
California, Louisiana as epicenters. As per 15th April, while the case fatality was 6.70% globally, the
case fatality in the US was 4.94%.
The cumulative Incidence (CmI) of COVID-19 mortality by race in selective US States and regions
is illustrated in Figures 1 and 2. The cumulative Incidence of COVID-19 mortality in selected states and
regions or cities with data on race reflects a relative increase in mortality of Blacks/AA with respect to
population size, and Whites. These states were IL, LU, MI, NY, NC (Figure 1A) and WI (Milwaukee
County). While Blacks/AA represent 13% of the population of the US as per US Census projection
(2020), overall mortality was 34% (n = 19,062), with a 21% excess cumulative incidence of dying as
per the 04/09/20 data with a total death of 5700. In the limited data on mortality by race, while Blacks
represent 6% of the CA population size, the mortality data indicated 8% (n = 21). With the population
size of Blacks/AA in LA county (8%), excess mortality was observed by the reported 16 deaths, (17%).
Similarly, whereas Blacks/AA represent 16% of the FL population, the mortality from the limited data,
n = 318 (race/ethnicity data not available, 354–318) was 20% among Blacks, n = 63.
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Figure 2. Cumulative incidence of COVID-19 mortality in mid-west states, USA, 9th April
2020. Co = county; in the mid-west states with data on race, mortality cumulative incidence (CmI) was
higher among Blacks/AA relative to Whites.

In the state of Illinois, Blacks/AA represent an estimated 14% of the total population but the CmI
was 46%, n = 225. The population of Blacks/AA in Chicago is 29% but the mortality from COVID-19
was 70% (n = 132). Blacks/AA comprise 32% of the Louisiana state population but represented 71%
(n = 495) of the total deaths (n = 702). The Black/AA in Michigan constitute 14% of the total population
but the mortality was 53% (n = 430).
In NY state, Blacks/AA comprised 16% of the total population but illustrated 22% of mortality
(n = 659). Similarly, while Latino constituted an estimated 19% of the NY state residents, there was a
24% (n = 714) mortality CmI. In contrast, whereas the population size of non-Hispanic or non-Latino
Whites in NY state is 55%, the CmI was 43% (n = 1278) of the total deaths, n = 2940, which is different
from the total deaths as per 04/9/20 since race and ethnicity data were not available in most cases
(7067—2940 cases). In NY city, Blacks/AA represent 24% of the total population, but mortality was 28%
(n = 428), while Latino constitute an estimated 29% of the population but mortality was 34%.
In North Carolina, Blacks/AA represent 21% of the total population but the CmI of mortality was
38%, n = 23. The population size of Blacks/AA in Milwaukee county is 26%, but the CmI was 66%
(n = 45). Michigan remains the third epicenter for COVID-19 next to New Jersey, with New York as
the number one epicenter in the US. The case fatality in MI as per 15 April was 6.66%, while that of
Detroit, the leading epicenter with the highest proportion of Blacks/AA was 6.85%. With the case of
fatality in the US, estimated at 4.93% during the same period, COVID-19 mortality disproportionately
affects Detroit and Blacks/AA in the city. The mortality proportion in St. John the Baptiste Parish, LU
as per mid-April was 7.9%. This population is characterized by environmental pollutants as a result of
proximity to chemical plants and refineries.
The frequency of deaths adjusted for the population size in the mid-western states is shown in
Figure 2. With the available data on race/ethnicity, Blacks/AA represent an estimated 34% of the total
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Figure 2. Cumulative incidence of COVID-19 mortality in mid-west states, USA, 9th April 2020. Co =

US COVID-19 deaths but make up 12.5–13% of the total US population, indicative of the excess burden
county; in the mid-west states with data on race, mortality cumulative incidence (CmI) was higher
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among Blacks/AA relative to Whites.
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3
0.67
Unknown
1354
21
1.55
Unknown 2
1354
21
1.55
21.5(4), <0.001
Maryland
2
Maryland
21.5(4), <0.001
Black/AA
3202
104
3.25
White
3.60
Black/AA
3202 2305
104 83
3.25
Asian
4.21
White
2305 190
83 8
3.60
Other
861
12
1.39
Asian
190 1667
8 28
4.21
Unknown
1.68
Other
861
12
1.39
Data Source, Abbreviations and Notes: Maryland Health Department, MD. AA = African Americans, χ2 = chi
Unknown
1667of freedom. 1 = Initial 28
square
statistic, df = degree
data on April 9th, while 2 =1.68
data on April 13th. The type I error

tolerance,
p–value
was set at 5%and
(0.05).
Data Source,
Abbreviations
Notes: Maryland Health Department, MD. AA = African Americans,

χ2 = chi square statistic, df = degree of freedom. 1 = Initial data on April 9th, while 2 = data on April

Table
2 demonstrates
the casep–value
fatalitywas
in set
Illinois,
Michigan and Detroit. In Illinois, the
13th. The
type I error tolerance,
at 5% Chicago,
(0.05).
frequency of confirmed cases among Blacks in 9th April was 4209, with 200 deaths resulting in case
Table
2 demonstrates
case among
fatalityWhites
in Illinois,
Michigan
and Detroit.
In Illinois,
the
fatality
of 4.8%,
while a casethe
fatality
wasChicago,
4.2%. In Chicago
during
the 9th April,
the case
2
frequency
of
confirmed
cases
among
Blacks
in
9th
April
was
4209,
with
200
deaths
resulting
in
case
fatality among Blacks/AA was 4.5%, while among Whites it was 2.0%, χ (2) = 52.6, p < 0.001. On 13th
fatality of 4.8%, while a case fatality among Whites was 4.2%. In Chicago during the 9th April, the
case fatality among Blacks/AA was 4.5%, while among Whites it was 2.0%, χ2(2) = 52.6, p < 0.001. On
13th April there was an increase in case fatality in both races, with Blacks/AA bearing the greater
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April there was an increase in case fatality in both races, with Blacks/AA bearing the greater burden of
mortality. The case fatality in Blacks/AA was 5.9% and 3.2% for Whites, χ2 (2) = 110.8, p < 0.001. The
period percent change (PPC) for Blacks/AA was 31.0% and for Whites, 59.4%, indicative of a positive
trend in mortality by these races. A racial variance was observed in CmI and case fatality in Michigan
state. The case fatality for Black was 7.4%, while 8.0% was observed among Whites, χ2 (2) = 126.8, p
< 0.001. Although specific data are unavailable during this preliminary study, Detroit in Michigan
illustrates case fatality disadvantage for Blacks/AA, with Blacks/AA relative to Whites observed to be
5.5 times as likely to die from COVID-19.
Table 2. COVID-19 case fatality in Illinois, Chicago, Wisconsin by race, the 9th through to the 13th
April 2020.
Race
Illinois
Black/AA
White
Unknown
Chicago1
White
Black/AA
Unknown
Chicago2
White
Black/AA
Unknown
Wisconsin *
White
Black/AA
Unknown
Michigan
Black/AA
White
Unknown

Confirmed Cases (n)

Frequency of
Deaths (n)

Fatality
Proportion (%)

4207
4002
3987

200
167
32

4.75
4.17
0.80

941
2102
1450

19
95
7

2.02
4.52
0.48

1209
3005
2540

39
178
15

3.22
5.92
0.59

1726
862
648

83
64
1

4.81
7.43
0.15

8460
6922
7947

625
577
305

7.39
8.05
3.84

χ2 (df), p
110.2(2), <0.001

52.6(2), <0.001

110.8(2), <0.001

42.0(2), <0.001

126.8(2), <0.001

1 = Initial data on April 9th, while 2 = data on April 13th, 2020. χ2 = chi square, df = degree of freedom, p = probability
value for the random error quantification which was set at 5% (0.05) type 1 error tolerance. * Wisconsin reflects the
assessment of the COVID-19 case fatality and mortality data from the Milwaukee City and County.

Although not illustrated in the table, the Illinois state had a total number of confirmed cases, n =
15,078, mortality, n = 462, with a case fatality of 3.06% on Wednesday, (4/8/20), while, on Thursday
(9th April) there was a case fatality of 3.22% (case, n = 16,422, deaths, n = 528). As per US census
projection, 2020, Blacks/AA comprise 14.6% of the Illinois population, but represent 27.9% and 43.2%
of COVID-19 confirmed cases and mortality, respectively. The Wisconsin data on 13th April indicate
the total confirmed cases, n = 3428, female n = 1817 (53%) and male n = 1611 (47%), mortality: male
n = 92 (60%) and female n = 62 (40%). The Milwaukee County cases as per 13th April was n = 1743,
and 94 deaths. In Wisconsin, Blacks represent an estimated 6.7% of the population by the 2019 US
census estimate but constituted 25% (n = 862) of all the confirmed cases and 42% (n = 64) of all deaths.
Table 3 demonstrates the Black–White risk differentials in case fatality with binomial regression
models in MI, MD, IL, WI and the city of Chicago. The cumulative incidence risk of dying reflects the
exposure function of race in COVID-19 mortality in these states and Chicago. There was a survival
disadvantage for Blacks/AA with COVID-19 during the month of April 2020 in Michigan, with a
significant 15% increased risk of dying relative to Whites, CmI risk ratio (RR) = 1.15, 95% CI, 1.01–1.32.
Relative to Whites in Maryland, there was a 5% increased risk of dying from COVID-19 among Black
residents compared to Whites, RR = 1.05, 95% CI, 0.70–1.39. The state of Illinois observed a 13%
increased risk of dying for Blacks/AA compared to Whites, RR, 1.13, 95% CI, 0.93–1.39. A 51% increased
risk of dying was observed among Blacks relative to Whites in the state of Wisconsin, with most data
from Milwaukee city and Milwaukee County, RR = 1.51, 95% CI, 1.10–2.10. In the city of Chicago,
Blacks/AA were more than two times as likely to die from COVID-19 relative to Whites, implying
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that for everyone White death from COVID-19, more than two Blacks/AA will die, RR = 2.24, 95% CI,
1.35–3.88.
Table 3. Black–White Risk Differentials in Mortality in Selected States, MD, MI, IL, the 9th through to
the 13th of April 2020.
State/Race
Michigan
White
Black/AA
Maryland
White
Black
Illinois
White
Black/AA
City/Race
Chicago1
White
Black/AA
Chicago2
White
Black/AA
Wisconsin
White
Black

CmIRR

95% CI

p

1.00
1.15

referent
1.01–1.32

referent
0.04

1.00
1.05

referent
0.70–1.58

referent
0.81

1.00
1.13

referent
0.93–1.39

1.00
2.24

EAF (%,95% CI)

PAF (%)

5.0(−42–36.5)

2.8

referent
0.22

11.7(−1.0–28)

6.0

referent
1.36–3.88

referent
0.001

55.3(25.5–71.)

46.1

1.00
1.79

referent
1.27–2.51

referent
0.001

44.0(21.4–60.)

36.0

1.00
1.51

referent
1.10–2.10

referent
0.01

34.0 (9.0–52.0)

15.0

PAF = Population attributable fraction, EAF = Exposure attributable fraction, AA = African American, p = probability
value for the random error quantification which was set at 5% (0.05) type 1 error tolerance. CmIRR = cumulative
incidence risk ratio. 1 = Initial data on April 9th, while 2 = data on 13th April 2020.

4. Discussion
With the current COVID-19 pandemic, and the USA with the highest confirmed cases and mortality
globally as well as the disproportionately observed mortality in some subpopulations, there remains an
urgent need to examine these data, provide a possible explanation to the observed racial disparities and
propose feasible recommendations in racial gap narrowing in COVID-19 mortality. Aggregate data were
utilized from the various state departments of health, where demographic information was available
to determine the racial variances in the confirmed cases and mortality as well as risk differentials,
comparing the Whites to the Black/AA subpopulation deaths. This preliminary study provides a few
relevant findings to epidemic curve flattening and case fatality mitigation in the communities of color,
namely Blacks/AA. First, of the limited data on race examined in the selected states and cities with race
information, Blacks/AA despite the population size of 13% in the US, represented 34% of all deaths in
the referenced states and cities. Secondly, there was a disproportionate burden of COVID-19 mortality
among Blacks/AA. Thirdly, the case fatality was higher among Blacks/AA relative to Whites. Fourthly,
Blacks/AA relative to Whites in all states and cities assessed for COVID-19 mortality had a higher risk
of dying, implying excess mortality.
This study has demonstrated that, despite the 13% population of Blacks/AA in the US, this
population represented an estimated 34% of all deaths from COVID-19 in mid-April 2020. The
observed population variance and the highest mortality among Blacks/AA had been observed in recent
media reporting [23,25–27]. The spread of pathogenic microbes such as viruses historically and to date
has been linked to social inequity, where the socially disadvantaged populations convey the highest
burden of the disease, including poor prognosis and mortality. The flu or influenza pandemic of the
1918 through 1919 in the US observed a lower cumulative incidence of the disease among Blacks but
higher mortality relative to Whites [18]. The current COVID-19 case confirmation among Blacks/AA
mirrors the observed lower cases or morbidity among Blacks, due to decreased effort by the US public
health system, local and county health departments and the healthcare institutions to provide the
assistance needed such as transportation for Blacks/AA to access the screening centers and sites.
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Secondly, Blacks/AA are less likely to be screened due to implicit bias [28] and lack of healthcare
resources, including private insurance through well-paying jobs relative to Whites [21–23]. Clearly,
the dynamics of viral pathogens reflects the penetrance in populations with compromised immune
systems, driven by structural poverty and food insecurity, which Blacks/AA are more predisposed
to compare to Whites. With non-restricted conditions and the relaxation of clinical guidelines in
infectious disease diagnosis during the pandemics, more cases are identified, isolated and contact
tracing is performed for more screening. This effort lowers the transmission and the spread of the
virus, enhances case detection, improves the prognosis and reduces case fatality at a population and
individual levels. Such initiative will reduce the unequal burden of morbidity and mortality now and
in future pandemics.
Thirdly, illiteracy rate and a lower level of education, which is higher in Blacks compared to
Whites due to structured racism and racial residential segregation that deprived Blacks/AA of the
opportunity of early childhood education, and quality early education had been observed to have
an adverse effect on the transmission and mortality from influenza virus during the 1918 pandemic
in Chicago [15]. Since Blacks/AA, historically had been perceived as a vulnerable population in
pandemics and in COVID-19, the public health and the affluent societal identification of COVID-19
burden and engagement with this subpopulation of the US society via national public health initiative,
will enhance a cooperative effort in data gathering and the understanding of the impact of a pandemic
on the overall wellbeing of the Black/AA populations across the nation.
The disproportionate burden of COVID-19 among Blacks/AA had been demonstrated in these
findings. Besides this, SARS-COV-2 pathogen in COVID-19, previous pandemics had observed
similar burden as in the flu pandemic of 1918 [14,15] and that of 2009 H1N1 influenza pandemic.
The observed disparities and the disproportionate burden among Blacks/AA is explained in part by
neighborhood-level social determinants, such as unemployment, educational level, housing and living
conditions and population density [7,10,29,30]. The epidemiologic modeling of these factors provides
reliable data in modulating these effects in anticipation of another pandemic, such as COVID-19-2.
The social determinants of health as an exposure function of social and health inequities has been
shown in the disproportionate burden in infant mortality, cancer, cardiovascular disease, stroke and
diabetes among Blacks/AA. These differentials, where Blacks/AA are at a higher risk of diseases, reflect
the unfair, unjust and inequitable distribution or allocation of social, economic and environmental
conditions related to health. Additionally, the disproportionate burden of disease as observed among
the socially disadvantaged populations, namely Blacks/AA and Hispanics, reflects structural racism,
which is different from interpersonal racism.
Racial residential segregation, the geographic clustering of racial and ethnic groups, has been
observed to predispose subpopulations to health disparities [31] as observed in this study. Black
neighborhoods in Milwaukee, New Orleans (LU), Houston (TX), Brooklyn (NY) Detroit (MI), and
South Chicago (IL) are densely populated within apartment buildings. The spread of pathogenic
microbes is enhanced by population density and close proximity as well as decreased hand hygiene
and environmental conditions, such as contaminants. For example, St. John the Baptiste community
in New Orleans, a Black/AA neighborhood, characterized by long-term exposure to environmental
pollutants (chemical plants and refineries) represented one of the geographic locations with the highest
case fatality in the US, 7.90% as per mid-April 2020. The long-term exposure to air pollutants have an
adverse effect on bronchopulmonary function, resulting in chronic respiratory diseases, such as asthma
and COPD. Specifically, the accumulation of air pollutants provokes the immune system response
through innate and adaptive mechanisms. However, with persistent insult to the immune system
adaptation, the host immune system remains incompetent with respect to macrophage activation and
neutrophil migration, CD4 cells’ activation and decreased cytokine elaboration, given macrophage
inability to present the processed antigen or viral pathogen to CD4 cells for activation and B cells or
immunoglobulin growth factors’ development and maturation. With COVID-19 implication in severe
respiratory symptoms, populations exposed to long-term air pollutants are expected to present with
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poorer prognosis and excess mortality from this pathogenic microbe. However, the attributable fraction
of exposed (AFE), given the environmental air pollutants in Blacks/AA neighborhoods observed in St.
John the Baptist community in LU, remains undetermined, pending the availability of sufficient data
in risk estimation.
Additionally, the observed burden of COVID-19 morbidity and mortality in Black/AA communities
is partially explained by workplace segregation, where Blacks/AA are employed in jobs with fewer or no
benefits, but with more adverse conditions, such as buildings with no fire exit [31,32], as well as a stressful
environment. Specifically, Blacks/AA who are employed as public transit drivers have an increased
risk of contracting viral microbes, which also explains the COVID-19 racial burden differentials.
This study also observed higher case fatality among Blacks/AA relative to Whites. Previous
studies in the flu pandemic of 1918 and 2009 clearly implicated the socially disadvantaged individuals
and populations in survival disadvantage following infectivity [18]. The case fatality is a proportion
of those who died as a result of an exposure, divided by all the exposed cohort as the population at risk for
mortality, multiplied by 100 in a proportion and not a rate, and reflects viral symptom severity and poor
prognosis from COVID-19. The excess case fatality among Blacks/AA is explained in part by the higher
prevalence of chronic diseases, namely hypertension and other cardiovascular diseases, diabetes and
cancer, as well as aberrant epigenomic modulation in COVID-19 prognosis and mortality. AA/Blacks
are more likely, compared to their White counterparts, to be diagnosed with type II diabetes, primary
or essential hypertension, stroke and cancer [16] and have higher mortality from these conditions [16].
The higher incidence of these conditions among Blacks/AA had been associated with a lack of access
to healthcare as well as decreased healthcare utilization due to several obstacles and barriers [19].
Secondly, the social determinants of health which reflect the needed resources to benefit from optimal
health is not equitably available for Blacks/AA. These determinants are characterized by the social
gradient upon which the socially disadvantaged individuals or populations are less likely to benefit
from early education, quality education through college and a good paying job. The social determinants
of health, namely education, socio-economic status, income, employment, food security, racism, safe
environment, insurance, transportation, and living conditions, adversely impacts the outcome of
morbidity and mortality in Black/AA populations in the US [33].
Since chronic health conditions render the biologic system vulnerable to microbes by compromising
the immune system responsiveness, the observed higher case fatality among Blacks/AA is explained in
part by the relatively higher prevalence of comorbidities among Blacks relative to Whites. While studies
have indicated genetic polymorphism in the predisposition to hypertension as well as epigenetics
and epigenomic modulations [34], not much had been considered regarding the interaction of
single-nucleotide polymorphism (SNP), epigenomics and the hypertension (HTN) genes involved in
immune system regulation. Available genetic and epigenetic studies have implicated hypertension
and cardiovascular disease candidate genes in immune system regulation, such as natriuretic peptide
B(NAPB1), nuclear factor of activated T cell (NFAT5), Human jagged 1 (JAG1), C-terminal Src Kinase
(CKS), Lymphocyte-specific protein 1 (LSP1), adrenomedullin (ADM), auxin-binding protein 1 (ABP1),
Feline sarcoma (FES) protein-tyrosine kinase (FES), angiotensin (AGT), serum/glucocorticoid-regulated
kinase 1(SGK1), adrenoceptor beta 1 (ADRB1), nerve growth factor receptor (NGFR), cytochrome
P450 family 1 subfamily A, member 1 and member 2 (CYP1A1, CYP1A2) and microtubule-associated
protein 4 (MAPB4) [35]. These genes mainly serve as negative regulators of B-cells (ABP1), suppress
T-cell migration and activation (LSP1), reduce T helper cells activities (ADM), down regulate innate
and adaptive immunity (FES) and suppress T cell proliferation.
The poorer prognosis and excess mortality of Blacks/AA with COVID-19 is in part explained by
the highest prevalence of primary HTN and other cardiovascular diseases in this population, due to the
candidate genes involved in immune system regulation that are implicated in HTN. In addition, it is
not merely the gene candidates but their interaction with the environment that results in transcription
factors or transcriptome dysregulation, which is necessary for immunomodulation. Addressing these
health inequities will require the public health utilization of a disproportionate universalism approach
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where the population with healthcare needs are provided equitable resources in transforming health
equity in the nation by environmental modification (toxic and air polluted neighborhood, poverty, low
income, illiteracy, lower education, violence, incarcerations, etc.).
Because Blacks are predisposed to more environmental pollutants and toxins, psychosocial
stressors, a dangerous job environment and incarceration, these environments interact with the gene,
implying impaired gene expression and increased disease development, poorer prognosis, increased
mortality and survival disadvantage. In addition, because social gradient reflects environmental
neighborhood characteristics, the understanding of gene and environment interaction, such as
living conditions, may provide an additional strategic approach in intervention mapping for disease
management and prevention. In effect, examining the gene and environment interaction, observed as
epigenomics, will provide substantial data on intervention in narrowing the gaps between Blacks and
Whites with respect to COVID-19 mortality.
Epigenomic modulations that commence at gametogenesis are transgenerational but reversible.
The social signal transduction that is evoked from the stress placed on Blacks/AA has a substantial effect
on the sympathetic nervous system and provokes the beta-adrenergic receptors. This response has
been shown to involve the Conserved Transcriptional Response to Adversity (CTRA) gene expression
and the consequent elaboration of pro-inflammatory cytokine due to the impaired gene expression
of the transcription factors and the inhibition of gene expression with respect to anti-inflammatory
response [36]. In understanding these pathways of genomic stability and their role in disease causation
as well as mortality, epigenomic studies are necessary in determining whether or not Black individuals,
relative to White individuals, have an increased mean deoxyribonucleic acid (DNA) methylation
index with respect to the genome-wide analysis. Such initiative will involve the utilization of
the bisulfite pyrosequencing that is very specific in differentiating between the methyl group and
hydroxyethyl group, as well as the binding of these groups to the Cytosine-phosphate-Guanine
(CpG) region of the gene, inhibiting transcription and the messenger ribonucleic acid (mRNA)
sequencing, leading to impaired gene expression and abnormal cellular functionality. The reference
to epigenomics investigation reflects the inability of a COVID-19 case to respond to treatment
modalities due to the drug receptors in-availability, resulting from impaired gene expression (mRNA
translation dysregulation) [37]. The observed epigenomic aberration clearly illustrates treatment effect
heterogeneity in which some subpopulations respond differentially to a given therapeutic agent in the
phase of epigenomic lesion, explaining in part racial risk differentials in COVID-19 case fatality.
We have illustrated that in the states with data on race, Blacks/AA, relative to Whites, had
an increased risk of mortality from COVID-19. The observed higher risk observed in mortality
among Blacks/AA, diagnosed with COVID-19 and treated for the disease had been observed in other
pandemics, namely the influenza flu of 1918 and 2009 N1H1 [18]. With respect to the geographic
locations such as states and cities, the risk ranged from 5% to more than twice as likely compared to
Whites (CmIRR, 1.05–2.24). The observed excess risk of dying among Blacks/AA may be explained by
the late detection of SARS-COV-2, implying poor prognosis, decreased access to identification and
isolation resources, a lack of healthcare resources, and poor-quality care, where Blacks/AA patients
are treated with implicit as well as clinician bias [20,25,37]. Also implicated in this excess risk is the
social determinants of health as previously observed, where the socially disadvantaged individuals or
populations are more predisposed to adverse health outcomes.
Despite the appropriate epidemiologic model used in this preliminary study to determine the
Black–White mortality risk differentials in COVID-19, there are some limitations. First, this study
used the only available data at this point, which is the aggregate data from the departments of public
health, which has a tendency for ecological fallacies. Secondly, there is a tendency for confoundability,
since data were not available to assess and control for the confounding in the risk estimation. Thirdly,
despite the sources of these data, complete race/ethnicity data were not available in these states and
cities utilized in this risk estimation. However, the interpretation of these data remains accurate
since an estimated >80% of the race/ethnicity data were available for this modeling. This preliminary

Int. J. Environ. Res. Public Health 2020, 17, 4322

15 of 18

study strongly recommends the collection and availability of race/ethnicity data from all states and
US territories for the understanding of COVID-19 population dynamics for racial/ethnic minority
populations’ engagement and preparedness in the future, for health equity transformation in epidemics
and pandemics.
5. Conclusions
In summary, racial disparities in COVID-19 case fatality exist and persisted and will continue to
persist unless data-driven scientific measures are implemented for racial/ethnic gap narrowing,
thus reducing the probability and likelihood of COVID-19-2. Additionally, Blacks/AA have a
disproportionate burden and increased risk of COVID-19 mortality compared to their White
counterparts. The observed racial disparities is explained by social determinants of health, where
Black individuals are exposed to environmental pollutants, social inequity, structural racism, food
insecurity, poor housing and living conditions, illiteracy, low SES, and a lack of healthcare resources.
Recommendations and Future Directions in Pandemic Health Equity Transformation
As part of the strategy in health disparity marginalization in future pandemics in avoiding the
emergence of COVID-19-2, this study recommends:
The USA, through the Affordable Care Act, to provide quality healthcare to all Americans,
especially Blacks/AA and Hispanics. Such a recommendation, if implemented and evaluated carefully,
will reduce the anticipated excess malignant neoplasm (absence of cancer screening and preventive
measure due to the pandemic), sleep disorders (sleep pattern alteration due to prolonged REM
and shortened non-REM), metabolic syndromes and CVDs (aberrant epigenomic modulation of
genes/transcriptome due to increased stressors associated with COVID-19) in populations of color,
mainly Blacks/AA and Hispanics.
Secondly, social and physical distancing and utilization of adequate PPE in the healthcare setting
until the epidemic curve is flattened in all states and territories prior to return to normal economic
life, will prevent a significant resurgence of COVID-19 with altered antigenicity or different serotype
(COVID-19-2).
Facemask application throughout the nation, especially among COVID-19 positives and
symptomatic individuals to marginalize the spread of the virus.
The immune system potentiation by providing equitable resources to Blacks/AA and Hispanics
who are socially disadvantaged with low SES.
The education of the Black/AA communities on the health consequence of COVID-19 and the
provision of assistance and encouragement for testing, case identification and isolation will flatten the
epidemic curve in the Black communities influencing epidemic curve flattening and down drifting in
the epidemic curve nationally, thus enhancing the overall US economy and return to normal life style
and coping. This initiative will not only reduce social inequities but the social inequities burden for
future disease and pandemics.
Since the disproportionate burden of pandemics fundamentally reflects health disparities,
addressing this disproportionate burden in future epidemics and pandemics will require
subpopulations, especially blacks/AA, American Indians/Alaska Native and Hispanics to be provided
with the resources necessary for optimal health. Therefore, adherence to the World Health
Organization’s recommendation of social justice and peace as conditions necessary for health is
essential in narrowing health disparities in pandemics by addressing now social injustice and systemic
and structural racism, thus transforming health equity.
The federal government through the Center for Disease Control and Prevention (CDC) and the
state health departments to increase testing throughout the nation, especially in the most vulnerable
COVID-19 population, namely Blacks/AA.
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The federal state and local/city government engagement with Black/AA community leaders in
assessing the individual and group risk for spread reduction, epidemic curve flattening and case
fatality stabilization and mitigation.
The development of a surveillance and monitoring system for data availability on the social
determinants on health and race/ethnicity in transforming pandemic health equity.
Since public health is the collective effort by society for all to remain healthy through disease control,
prevention and health promotion practices, academic institutions of public health and the healthcare
system should advocate professional inclusion and diversity in faculty positions and healthcare
provision. This perspective ensures the education of the communities of color on pandemic risk factors
in the first place and protective factors by those who are demographically comparable to them, and the
provision of care with marginalized implicit and clinician bias to racial and ethnic minorities.
Establishment and implementation of a rapid health equity transformation taskforce and evaluation
matrix for risk mitigation among racial and ethnic minorities, namely Blacks/AA and Hispanics.
The federal, state, county and local health departments collect socio demographic data for a better
understanding of exposures and confounding in viral spread and case fatality.
As we anticipate a vaccine against COVID-19, the administration of this vaccine must be
initiated among the most vulnerable populations, especially the socially disadvantaged population,
namely Blacks/AA and Hispanics for herd immunity in these subpopulations prior to other
communities’ immunizations.
As emergency preparedness, health equity resources are required through disproportionate
universalism, which is the public health lens in the provision of health services more to the racial/ethnic
minorities prior to the non-vulnerable populations. The failure to address the socially disadvantaged
individuals and populations’ needs in our society, by educational opportunity, equitable employment
opportunity and the departure from structural racism, will render the US population more vulnerable
to public health and healthcare crises in COVID-19-2. In effect, as clinicians, researchers, health officers,
epidemiologist, infectious disease specialist, and public health experts, it is our moral responsibility
regardless of our race/ethnicity, gender or age, to rapidly respond to the disproportionate mortality
burden of this pandemic in the communities of color, especially Blacks/AA, since human life remains a
primary value.
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